2 followers
#kidneycancer http://t.co/GiylVpkvQ4 This is our recently published indirect efficacy/safety comparison of therapies in 2nd-line setting
#kidneycancer http://t.co/GiylVpkvQ4 This is our recently published indirect efficacy/safety comparison of therapies in 2nd-line setting